Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Unlike platelet growth factors which will work directly on tendon or ligament cells, BPC-157 doesnt work that way, as it has no effect for example on tendon cells in culture, but does help tendon cells in animals (3)
"Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C Act." Federal Register, 2024
The objective is to get the compound near the tendon so it can permeate the surrounding tissue, not to puncture the tendon itself
BPC-157 does not develop traditional tolerance since it operates non-hormonally and does not suppress natural production
Not sure which BPC-157 protocol fits your goal
Phase 3 studies showed approximately 18% reduction in VAT after 26 weeks of treatment, alongside improvements in liver fat (NAFLD) and lipid profile metrics
